Resumen
Goal: To determine patient-reported financial and family burden associated with treatment of cancer in the previous 28 days across Canada. Methods: A self-administered questionnaire (P-SAFE v7.2.4) was completed by 901 patients with cancer from twenty cancer centres nationally (344 breast, 183 colorectal, 158 lung, 216 prostate) measuring direct and indirect costs related to cancer treatment and foregone care. Monthly self-reported out-of-pocket-costs (OOPCs) included drugs, homecare, homemaking, complementary/ alternative medicines, vitamins/supplements, family care, accommodations, devices, and “other” costs. Travel and parking costs were captured separately. Patients indicated if OOPC, travel, parking, and lost income were a financial burden. Results: Mean 28-day OOPCs were CA$518 (US Purchase Price Parity [PPP] $416), plus CA$179 (US PPP $144) for travel and CA$84 (US PPP $67) for parking. Patients self-reporting high financial burden had total OOPCs (33%), of CA$961 (US PPP $772), while low-burden participants (66%) had OOPCs of CA$300 (US PPP $241). “Worst burden” respondents spent a mean of 50.7% of their monthly income on OOPCs (median 20.8%). Among the 29.4% who took time off work, patients averaged 18.0 days off. Among the 26.0% of patients whose caregivers took time off work, caregivers averaged 11.5 days off. Lastly, 41% of all patients had to reduce spending. Fifty-two per cent of those who reduced spending were families earning < CA$50,000/year. Conclusions: In our Canadian sample, high levels of financial burden exist for 33% of patients, and the severity of burden is higher for those with lower household incomes.
Idioma original | English |
---|---|
Páginas (desde-hasta) | 3377-3386 |
Número de páginas | 10 |
Publicación | Supportive Care in Cancer |
Volumen | 29 |
N.º | 6 |
DOI | |
Estado | Published - jun. 2021 |
Nota bibliográfica
Funding Information:There were a number of individuals who assisted at the participating regional cancer centres providing instrumental support for patient recruitment and local study management and include Justin Jao (BC); Emma Tolsdorf (Alb); Zeb Aurangzeb, Elizabeth Harland, Carrie O’Conaill (Man); Melissa Korman, Laura Goldberg, Anne Malpage, Albert Gratton, Guilio Didiodato, Jesse Maclean, Christine DiMarco, and the Royal Victoria Regional Health Centre V-forces team, Carla Girolametto (Ont); Margaret Jorgensen (NS); and Dana Ryan (Nfld). The clinics included Toronto Sunnybrook Regional Cancer Centre, Juravinski Cancer Center, Princess Margaret Hospital, Grand River Regional Cancer Centre, Simcoe Muskoka Regional Cancer Centre, and the London Regional Cancer Program, four BC cancer centres, six Alberta cancer centres (excluding satellite centres), Saskatoon Cancer centre (Saskatchewan), CancerCare Manitoba–McDermot site, Nova Scotia Cancer Centre, and Dr. H. Bliss Murphy Cancer Centre (Newfoundland). Statistical assistance was provided by Rodrigo Juarez, Senior Statistician, Eli Lilly Canada Inc.
Publisher Copyright:
© 2021, The Author(s).
ASJC Scopus Subject Areas
- Oncology
PubMed: MeSH publication types
- Journal Article